CREB1 and early-onset autosomal dominant Alzheimer disease: Consistently, according to the prior research, SB203580 could raise the level of CREB phosphorylation in the hippocampus of mice with Alzheimer's disease, thereby improving the cognitive dysfunction in mice [38].